Quarterly report pursuant to Section 13 or 15(d)

Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details)

v3.21.2
Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net income (loss) available to stockholders $ 399,631 $ (653,888) $ 2,166,338 $ (1,856,275)
Weighted average shares outstanding - basic 24,850,261 24,850,261 24,850,261 24,850,256
Effect of dilutive securities:        
Weighted average shares outstanding - Diluted 25,125,210 24,850,261 25,102,470 24,850,256
Net income (loss) per share - basic (in USD per share) $ 0.02 $ (0.03) $ 0.09 $ (0.07)
Net income (loss) per share - diluted (in usd per share) $ 0.02 $ (0.03) $ 0.09 $ (0.07)
Stock Options        
Effect of dilutive securities:        
Stock options 274,949 0 252,209 0
Anti-dilutive shares underlying stock options outstanding 985,296 1,270,666 777,296 1,269,662